Dabigatran versus warfarin in patients with mechanical heart valves
作者:
Eikelboom,J.W. [1]
;
Connolly,S.J. [2]
;
Brueckmann,M. [3]
;
Granger,C.B. [4]
;
Kappetein,A.P. [5]
;
Mack,M.J. [6]
;
Blatchford,J. [7]
;
Devenny,K. [8]
;
Friedman,J. [9]
;
Guiver,K. [10]
;
Harper,R. [11]
;
Khder,Y. ;
Lobmeyer,M.T. ;
Maas,H. ;
Voigt,J.-U. ;
Simoons,M.L. ;
VanDeWerf,F.
作者单位:
Heart Hospital Baylor, Plano, TX, United States
[1]
Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States
[2]
McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada
[3]
Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands
[4]
Department of Cardiovascular Sciences, KU Leuven, University Hospitals Leuven, Herestraat 49, B
[5]
Boehringer Ingelheim, Bracknell, United Kingdom
[6]
Boehringer Ingelheim, Paris, France
[7]
Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands
[8]
Boehringer Ingelheim, Ingelheim am Rhein, Germany
[9]
Duke Clinical Research Institute, Durham, NC, United States
[10]
Boehringer Ingelheim, Ingelheim am Rhein, Germany, Faculty of Medicine Mannheim, University of
[11]
期刊:
发布时间:
2013-12-19
- 翻译满意度评价:
- 提交
- 浏览:0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文